Received Jul 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | Z007214 | — |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
patient did not experience any adverse side effects from administered dose; PROQUAD with a prior excursion on 6/18/2025 and a current excursion on 07/02/2025 that was administered post excursion to a patient on 07/01/2025; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 01-Jul-2025, the patient was vaccinated with and improper storage dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Z007214, expiration date: 05-Oct-2026), dose number 1, (0.5ml/once) (anatomical location and administration route were not reported) as prophylaxis; diluted in a sterile diluent (MERCK STERILE DILUENT), (lot # and expiration date were not reported), administered as prophylaxis. The reported stated that the Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) vaccine had a prior excursion on 18-Jun-2025 (of 6.8 Fahrenheit degrees (F) for 47 minutes) and a current excursion on 02-Jul-2025 (of 8.6 F for 1 hour, 17 minutes); that was administered post excursion to a patient on 01-Jul-2025. The nurse confirmed that the patient did not experience any adverse side effects.; Reporter's Comments: Keywords :